CVE-2025-24316
CVE-2025-24316 — Dario Health USB-C Blood Glucose Monitoring System Starter Kit Android Application Exposure of Sensitive Information Due to Incompatible Policies
The Dario Health Internet-based server infrastructure is vulnerable due to exposure of development environment details, which could lead to unsafe functionality.
Published Updated Sources: cvelistV5, icscert
Triage
Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.
Exploitation
Unreported
no source claims exploitation
EPSS
0%
chance of exploitation in 30 days
CVSS base
5.3
MEDIUM
CISA SSVC assessment
Three decision points CISA publishes for the CVEs it assesses · SSVC 2.0.3. A stakeholder decision, not a severity score.
Exploitation
None
none · proof-of-concept · active
Automatable
Yes
can an attacker script all four kill-chain steps
Technical impact
Partial
partial · total control of the vulnerable component
Affected scope
The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.
Vendors (1)
Products (1)
Every base score collected
Sources score independently and disagree; each row says who scored it and under which version.
| Score | Version | Severity | Expl. | Impact | Source |
|---|---|---|---|---|---|
| 5.3 | CVSS 3.1 | MEDIUM | — | — | cvelistV5 |
Weakness & attack patterns
- CWE-213
References
2 on the record
Elsewhere on this site
- dario healthevery CVE for this vendor
- CWE-213other pages naming this weakness
Not in any source we poll
Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.
- No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
- No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
- No exploit packet captures, log samples, or incident case IDs supplied.